Latest Strategy News

Maronan Metals has reported significantly improved metallurgical testwork results for its Maronan copper-gold deposit, with gold recoveries reaching up to 88% and copper recoveries exceeding 96% in primary ore types. These findings enhance confidence in the project’s processing potential and underpin ongoing feasibility studies.

Bank of Queensland has appointed Rod Finch as its new CEO, marking a leadership transition aimed at continuing its strategic transformation and operational improvements.

Northern Minerals has identified a promising new heavy rare earths target, the Vulcan prospect, through extensive drilling and soil sampling at its Browns Range project in Western Australia. This discovery, alongside advances in geological modelling and AI-driven exploration, signals a strategic step forward in the company’s rare earths ambitions.

Strategic Energy Resources has completed key diamond drilling programs at Isa North and Canobie projects, revealing potential IOCG mineralisation and advancing its copper-gold portfolio with the acquisition of the Diamantina Project from Anglo American.

True North Copper Limited has released an updated Mineral Resource Estimate for its Wallace North copper-gold deposit, showing a 12% increase in tonnes and supporting ongoing development of the Cloncurry Copper Project in Queensland.

Great Southern Mining's recent aircore drilling at the Mon Ami Gold Project in Western Australia has revealed promising gold intercepts, suggesting potential extensions to the existing resource and new parallel lodes.

Future Metals NL has outlined strategic initiatives to enhance its flagship Panton PGM Project, leveraging rising platinum group metal prices and new processing opportunities. Key work programs and management appointments position the company for accelerated development in 2026.

Stakk Limited has surged to an $8.53 million annual recurring revenue run-rate in 2025, propelled by its acquisition of Radical DBX and strong SaaS growth. The fintech’s strategic moves position it for breakeven and further expansion in 2026.

Aurelia Metals announces Managing Director Bryan Quinn will resign by July 2026, with a leadership search underway amid key project developments.

Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.

Patrys Limited has acquired Reliis, gaining a promising injectable formulation of quetiapine aimed at treating delirium with a rapid FDA approval pathway. This move positions Patrys at the forefront of addressing a significant unmet medical need in critical care.

Patrys Limited has completed its acquisition of Reliis Pty Ltd, adding a promising injectable quetiapine program to its clinical pipeline and strengthening its board with two new directors.